HIV-1 Drug Resistance Mutations and Their Clinical Implications in South Korea-Reference-Cited by-同舟云学术

HIV-1 Drug Resistance Mutations and Their Clinical Implications in South Korea

Published:2022-04-01 Issue:2 Volume:12 Page:100-108
ISSN:2093-6338
Container-title:Laboratory Medicine Online
language:en
Short-container-title:Lab Med Online

Author:

Yun Jiwon¹,Jung Kiwook¹,Park Jae Hyeon¹,Bang Ji Hwan²,Kim Namhee³,Roh Eun Youn³⁴,Shin Sue³⁴,Yoon Jong Hyun³⁴,Park Hyunwoong³⁴^ORCID

Affiliation:

1. Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Korea

2. Division of Infectious Diseases, Seoul Metropolitan Government - Seoul National University Boramae Medical Center, Seoul, Korea

3. Department of Laboratory Medicine, Seoul National University Boramae Medical Center, Seoul, Korea

4. Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Korea

Publisher

Laboratory Medicine Online

Subject

Industrial and Manufacturing Engineering

Link

http://pdf.medrang.co.kr/LMO/2022/012/LMO012-02-100.pdf

Reference24 articles.

1. CDC NCHHSTP. New HIV Infections Drop 18 Percent in Six Years. https://www.hiv.gov/blog/new-hiv-infections-drop-18-percent-in-six-years (Updated on Feb 2017).

2. Effectiveness and cost-effectiveness of potential responses to future high levels of transmitted HIV drug resistance in antiretroviral drug-naive populations beginning treatment: modelling study and economic analysis

3. Panel on Antiretroviral Guidelines for Adults, Adolescents. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/AdultandAdolescentGL.pdf (Updated on Aug 2021).

4. Characteristics of Transmitted Drug-Resistant HIV-1 in Recently Infected Treatment-Naive Patients in Japan

5. Drug resistance mutation profiles of the drug-naïve and first-line regimen-treated HIV-1-infected population of Suzhou, China